Myomo (MYO) Accounts Payables (2016 - 2025)
Myomo (MYO) posted Accounts Payables of $5.8 million for Q4 2025, down 12.72% on a QoQ basis from $6.7 million in Q3 2025, and down 35.49% year-over-year from $9.0 million in Q4 2024.
Myomo (MYO) Accounts Payables (2016 - 2025) Analysis & Trends
Myomo's Accounts Payables history runs 10 years deep, the most recent figure standing at $5.8 million for Q4 2025.
- Quarterly Accounts Payables fell 35.49% year-over-year to $5.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.8 million (down 35.49% YoY) and the FY2025 annual result came in at $5.8 million, down 35.49% from the prior year.
- Accounts Payables was $5.8 million for Q4 2025 at Myomo, down from $6.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $10.4 million in Q1 2025 and bottomed at $2.9 million in Q2 2021.
- A 5-year average of $5.2 million and a median of $4.6 million in 2022 frame the typical range for Accounts Payables.
- Peak annual rise in Accounts Payables reached 110.5% in 2025, while the deepest fall reached 35.49% in 2025.
- Myomo's Accounts Payables stood at $3.9 million in 2021, then decreased by 18.7% to $3.2 million in 2022, then soared by 53.68% to $4.9 million in 2023, then jumped by 84.65% to $9.0 million in 2024, then tumbled by 35.49% to $5.8 million in 2025.
- Business Quant data shows MYO's Accounts Payables at $5.8 million in Q4 2025, $6.7 million in Q3 2025, and $8.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | 5.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Jun 30, 2025 | 8.31 Mn |
| Mar 31, 2025 | 10.45 Mn |
| Dec 31, 2024 | 9.02 Mn |
| Sep 30, 2024 | 6.45 Mn |
| Jun 30, 2024 | 5.87 Mn |
| Mar 31, 2024 | 4.96 Mn |
| Dec 31, 2023 | 4.89 Mn |
| Sep 30, 2023 | 5.23 Mn |
| Jun 30, 2023 | 3.98 Mn |
| Mar 31, 2023 | 3.48 Mn |
| Dec 31, 2022 | 3.18 Mn |
| Sep 30, 2022 | 3.65 Mn |
| Jun 30, 2022 | 3.45 Mn |
| Mar 31, 2022 | 4.24 Mn |
| Dec 31, 2021 | 3.91 Mn |
| Sep 30, 2021 | 3.42 Mn |
| Jun 30, 2021 | 2.90 Mn |
| Mar 31, 2021 | 3.89 Mn |